Want to collaborate with us?
Charlton Morris is a Talent Solutions business who offer search, contract, volume and employer branding solutions to the industrial markets.Feature in podcasts, videos, articles and more.
Dx Digest: Adapting to Survive: Rapid Testing Strategies with COVID's Chief Pathology Advisor.
In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with David Wells, Chief Executive Officer of the Institute of Biomedical Science (IBMS).
With over 21,000 members in 74 countries, IBMS is the leading professional body for scientists, support staff and students in the field of biomedical science. For over 100 years, it has been dedicated to the promotion, development and delivery of excellence in biomedical science within all aspects of healthcare, and to providing the highest standards of service to patients and the public.
We discuss the NHS response to rapid testing, the importance of the IBMS and its members as an organisation and what's to come during its biggest conference. Until June 2021 David led the NHS England and NHS Improvement Pathology consolidation programme, seeking to deliver efficient, high quality and innovative pathology services across England.
Now appointed Chief Executive of the IBMS, as an expert advising on policy, strategy and technology deployment, he shares fascinating insights from his experiences at the helm of the biggest healthcare challenge the world has ever seen.
If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at nathan.sharpe@lifesci-cm.com or let's connect on LinkedIn.
Recommended.
-
26 January 2023Breaking Down Corporate Development.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
-
18 January 2023How Has AI Revolutionised Diagnostics?
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
-
11 January 2023Diversifying Diagnostics to Make a Difference.
In this episode, Nathan speaks with Richard Acton, former CSO at Cignpost Diagnostics, about transitioning a company from a COVID testing business to a health and wellness business.
Comments.